FDA Inspection 998487 — Alvogen, Inc
The FDA completed an inspection of Alvogen, Inc on Jan 18, 2017 in Morristown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Morristown, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)